The extracts of Aquilaria crassna pericarp were investigated on the MDA-MB-468, a breast cancer cell
line, at desired concentration (1–50 μg/mL). The results
showed that the dichloromethane (DCM) extract exhibited the strongest
toxicity and was carried out subsequently. A total of nine compounds
were isolated from the DCM extract using column chromatography and
recrystallization, of which their structures were determined. Intriguingly,
in addition to the previously reported compounds, neocucurbitacin
A, a cucurbitacin triterpenoid aglycone with a lactone in ring A,
was reported for the first time in the Aquilaria genus. Among the isolated compounds, cucurbitacin E highly inhibited
MDA-MB-468 cell growth in a dose-dependent manner. Owing to binding
abilities with the SH2 domain in the molecular docking study, cucurbitacin
E, neocucurbitan A, neocucurbitan B, and cucurbitacin E 2-O-β-d-glucopyranoside act as STAT3 inhibitors
and are suitable for further research. This study suggests thatAquilaria crassnafruits could serve as a promising
source of natural compounds with potential anticancer effects, particularly
against breast cancer.